menu
    • menu

    Company profile for STADA Arzneimittel

    NEW Drugs in Dev: 4
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for 125 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop ...
    STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for 125 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally. STADA focuses on a two pillar strategy consisting of generics, including specialty pharmaceuticals and non-prescription consumer healthcare products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    STADA ArzneimittelGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Stadastraße 2-18 61118 Bad Vilbel
    Telephone
    Telephone
    06101 603-0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.stada.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/stada

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    STADA and Bio-Thera Secure EU Approval for Gotenfia
    STADA and Bio-Thera Secure EU Approval for Gotenfia

    14 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/stada-and-bio-thera-receive-european-marketing-authorization-for-gotenfia-a-biosimilar-to-simponi-302687571.html

    PR NEWSWIRE
    14 Feb 2026
    Share Share
    Stada’s Kefdensis Receives Approval In Europe
    Stada’s Kefdensis Receives Approval In Europe

    17 Nov 2025

    // EMA

    https://www.ema.europa.eu/en/documents/overview/kefdensis-epar-medicine-overview_en.pdf

    EMA
    17 Nov 2025
    Share Share
    Stada’s Zvogra Receives Approval In Europe
    Stada’s Zvogra Receives Approval In Europe

    17 Nov 2025

    // EMA

    https://www.ema.europa.eu/en/documents/overview/zvogra-epar-medicine-overview_en.pdf

    EMA
    17 Nov 2025
    Share Share
    Stada’s Usgena Receives Approval In Europe
    Stada’s Usgena Receives Approval In Europe

    17 Nov 2025

    // EMA

    https://www.ema.europa.eu/en/documents/overview/usgena-epar-medicine-overview_en.pdf

    EMA
    17 Nov 2025
    Share Share
    EMA Recommends Marketing Authorization of AVT03
    EMA Recommends Marketing Authorization of AVT03

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3153748/0/en/European-Medicines-Agency-Recommends-Marketing-Authorization-of-AVT03-Alvotech-s-Proposed-Biosimilar-to-Prolia-and-Xgeva.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    CapVest to Acquire Majority Stake in STADA from Bain Capital
    CapVest to Acquire Majority Stake in STADA from Bain Capital

    01 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250901671846/en/CapVest-to-Acquire-Majority-Stake-in-STADA-from-Bain-Capital-and-Cinven

    BUSINESSWIRE
    01 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search